Safety and feasibility of estrogen receptor-β targeted phytoSERM formulation for menopausal symptoms: phase 1b/2a randomized clinical trial.
- Resource Type
- journal article
- Source
- Menopause (10723714); Aug2019, Vol. 26 Issue 8, p874-884, 11p
- Subject
- Language
- ISSN
- 10723714